| Literature DB >> 31060558 |
Thach Xuan Tran1, Trang Thu Le1, Long Phi Trieu2, Christopher M Austin3, Dong Van Quyen4,5, Huong Minh Nguyen6.
Abstract
BACKGROUND: Invasive meningococcal disease (IMD) persists in military units in Vietnam despite the availability of antibiotics and vaccines. A hindrance to reducing the incidence of IMD in Vietnam is a lack of molecular data from isolates of the causative agent, Neisseria meningitidis from this country. Here, we characterized key genetic and epidemiological features of an invasive N. meningitidis isolate from a military unit in Vietnam using whole-genome sequencing.Entities:
Keywords: Antibiotic resistance; Antigen sequence typing; Epidemiological characterization; Neisseria meningitidis; Next generation sequencing; Vietnam
Mesh:
Substances:
Year: 2019 PMID: 31060558 PMCID: PMC6501280 DOI: 10.1186/s12941-019-0315-z
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Epidemiological characterization of DuyDNT isolate and other related isolates worldwide
| Isolate | Country | Year | Status | Capsule group | ST | PorA VR1 | PorA VR2 | FetA VR | fHBP | NHBA |
|---|---|---|---|---|---|---|---|---|---|---|
| M3369 | Italy | IMD | NA | 1576 | ||||||
| Mrs2008309 | Vietnam | 2008 | B | 1576 | 22 | 9 | ||||
| Mrs2008310 | Vietnam | 2008 | B | 1576 | 22 | 26 | ||||
| Mrs2008311 | Vietnam | 2008 | NG | 1576 | 19 | 15–39 | ||||
| Mrs2008312 | Vietnam | 2008 | NG | 1576 | 19 | 15–39 | ||||
| 13,515 | Vietnam | 1986 | IMD | B | 11,013 | |||||
| DuyDNT | Vietnam | 2014 | IMD | B | 13,074 | 22–25 | 14–32 | F4–6 | 31 | 16 |
| 17,088 | Vietnam | 2017 | C | B | 13,074 | 22–25 | ||||
| 17,090 | Vietnam | 2017 | C | B | 13,074 | 22–25 | 14 | |||
| Bach | Vietnam | 2013 | IMD | B | 13,455 | 19 | 15 |
NA information not available, NG non-groupable, IMD invasive meningococcal disease, C carrier
Antibiotic susceptibility result of N. meningitidis isolate from Vietnam
| Antibiotics | MIC breakpoints (μg/ ml)a | MIC value (μg/ ml) | Susceptibility | ||
|---|---|---|---|---|---|
| S | I | R | |||
| Ampicillinb | ≤ 0.12 | 0.25–1 | ≥ 2 | 0.5 | I |
| Ciprofloxacinb | ≤ 0.03 | 0.06 | ≥ 0.12 | 0.008 | S |
| Cefotaxime | ≤ 0.12 | – | – | 0.016 | S |
| Ceftriaxone | ≤ 0.12 | – | – | 0.004 | S |
| Rifampicinb | ≤ 0.5 | 1 | ≥ 2 | 1.5 | I |
| Meropenem | ≤ 0.25 | – | – | 0.094 | S |
| Chloramphenicol | ≤ 2 | 4 | ≥ 8 | 256 | R |
aAccording to CLSI 2018 guideline
bAntibiotics currently used in meningitis prophylaxis in Vietnam
Fig. 1Circular view of the genome of N. meningitidis DuyDNT isolate generated by PATRIC showing the physical map of its significant features. From outside in: Order of contigs (shown in navy); distribution of coding sequences in plus and minus strands (shown in green and purple, respectively); distribution of noncoding elements along the chromosome (shown in blue); distribution of genes involved in antibiotic resistance (shown in red); distribution of other virulence genes (shown in orange); distribution of genes encoding transmembrane proteins (shown in dark blue); distribution of genes encoding drug targets (shown in black); distribution of GC content along plus and minus strands (most inner two circles)
Resistance-associated genes identified in N. meningitidis DuyDNT isolate
| PATRIC ID | Source ID | Resistance Gene | Antibiotic class | Identity |
|---|---|---|---|---|
| fig|487.2031.peg.475 | NP_273462.1 |
| Beta-lactam resistance | 96 |
| fig|487.2031.peg.1487 | AAB51421.1 |
| Chloramphenicol resistance | 100 |
| fig|487.2031.peg.154 | AAA50993.1 |
| Elfamycin resistance | 84 |
| fig|487.2031.peg.138 | AAA50993.1 |
| Elfamycin resistance | 84 |
| fig|487.2031.peg.620 | AAV85982.1 |
| Erythromycin resistance | 98 |
| fig|487.2031.peg.619 | AAV85981.1 |
| Erythromycin resistance | 96 |
| fig|487.2031.peg.1534 | YP_207769.1 |
| Fluoroquinolone resistance | 97 |
| fig|487.2031.peg.1792 | YP_208330.1 |
| Fluoroquinolone resistance | 97 |
| fig|487.2031.peg.186 | WP_002215466.1 |
| Isoniazid resistance | 100 |
| fig|487.2031.peg.1920 | NP_274719.1 |
| Multidrug efflux | 98 |
| fig|487.2031.peg.359 | NP_273368.1 |
| Multidrug efflux | 98 |
| fig|487.2031.peg.1919 | NP_274718.1 |
| Multidrug efflux | 99 |
| fig|487.2031.peg.358 | NP_273367.1 |
| Multidrug efflux | 99 |
| fig|487.2031.peg.1921 | YP_002002225.1 |
| Multidrug efflux | 97 |
| fig|487.2031.peg.155 | YP_208874.1 |
| Tetracycline resistance | 100 |
Frequency of prominent repetitive DNA sequences in DuyDNT genome
| Motifs | Repetitive sequences | ||||
|---|---|---|---|---|---|
| DUS | GCCGTCTGAA | 1864 | 1935 | 2247 | 445 |
| AT-DUS (eDUS) | ATGCCGTCTGAA | 1449 | 1477 | 1718 | 1520 |
| vDUS | GTCGTCTGAA | 173 | 165 | 90 | 120 |
| AG-DUS | AGGCCGTCTGAA | 181 | 214 | 262 | 192 |
| AG-mucDUS | AGGTCGTCTGAA | 102 | 88 | 45 | 83 |
| veDUS | ATGTCGTCTGAA | 20 | 19 | 8 | 9 |
| DSR3 | ATTCCCNNNNNNNNGGGAAT | 828 | 1378 | 454 | 430 |
| Correia | ATAG[CT]GGATTAACAAAAATCAGGAC | 166 | 181 | 50 | 78 |
| TATAG[CT]GGATTAAATTTAAACCGGTAC | 1 | 0 | 1 | 23 | |
| TATAG[CT]GGATTAACAAAAACCGGTAC | 5 | 8 | 17 | 40 | |
| TATAG[CT]GGATTAAATTTAAATCAGGAC | 26 | 24 | 17 | 21 | |
| Totala | 151 | 209 | 152 | 131 | |
aPerformed by tandem repeat finders [29]
Prophage regions in genomes of DuyDNT and MC58
| Isolate | Region 1 | Region 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Region length (kb) | Total proteins | Status | Closest known phage | Region length (kb) | Total proteins | Status | Closest known phage | ||
| DuyDNT | 35.3 | 41 | Intact | PHAGE_Pseudo_YMC11/02/R656_NC_028657 | 12 | 12 | Partial | PHAGE_Haemop_SuMu_NC_019455 | |
| MC58 | 24.6 | 29 | Partial | PHAGE_Burkho_BcepIL02_NC_012743 | 32.8 | 49 | Intact | ||